Skip to content
The Policy VaultThe Policy Vault

desonideCareFirst (Caremark)

Treatment of psoriasis

Initial criteria

  • Authorization may be granted when the requested drug is being prescribed for a corticosteroid-responsive dermatosis or condition (e.g., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) AND
  • The requested drug is NOT being used in a footbath

Approval duration

6 months